Table 1.
Group P (n = 36) | Group R (n = 36) | Standardized Difference | |
---|---|---|---|
Sex (male/female) | 23/13 | 19/17 | 0.227 |
Age (years) | 50.3 [33–66] | 54.2 [27–66] | 0.447 |
Height (cm) | 168.0 (6.2) | 165.8 (9.5) | 0.272 |
Weight (kg) | 65.5 (11.6) | 65.0 (9.4) | 0.050 |
Diagnosis | |||
Stenosis | 17 (47.2%) | 14 (38.9%) | 0.169 |
Disc herniation | 8 (22.2%) | 9 (25.0%) | 0.065 |
Cervical myelopathy | 3 (8.3%) | 7 (19.4) | 0.326 |
OPLL | 3 (8.3%) | 3 (8.3%) | 0 |
Others | 5 (13.9%) | 3 (8.3%) | 0.178 |
Past medical history | |||
Smoking | 15 (41.7%) | 9 (25.0%) | 0.359 |
Steroid use | 3 (8.3%) | 2 (5.6%) | 0.109 |
Psychiatric medication | 3 (8.3%) | 4 (11.1%) | 0.094 |
Comorbidities | |||
Hypertension | 9 (25.0%) | 6 (16.7%) | 0.206 |
DM | 4 (11.1%) | 4 (11.1%) | 0 |
Cardiac | 0 | 3 (8.3%) | 0.426 |
Respiratory | 4 (11.1%) | 9 (13.9%) | 0.084 |
Others | 6 (16.7%) | 4 (11.1%) | 0.161 |
Values are expressed as number of patients, means (standard deviations) (except age: mean [range]), or numbers (percentiles). Abbreviations: DM, diabetes mellitus; OPLL, ossification of posterior longitudinal ligament; P, propofol; R, remimazolam.